secwatch.observer — SEC 8-K summary
======================================

Issuer:     Candel Therapeutics, Inc. (CADL)
CIK:        0001841387
Form:       8-K
Filed at:   2026-09-09T20:50:50+00:00
Accession:  0001193125-26-386561
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Candel Therapeutics files investor presentation; no new material facts disclosed
--------------------------------------------------------------------------------

- Candel Therapeutics furnished a corporate investor presentation dated September 2026 under Regulation FD.
- Visible exhibit content is limited to the cover slide; no financial or clinical data is included in the filing text.
- Presentation tagline: 'Tipping the balance in favor of the immune system to fight cancer.'
- No earnings, guidance, or pipeline updates are disclosed in this 8-K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1841387/000119312526386561/0001193125-26-386561-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1841387/000119312526386561/d738484d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-386561

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer